|
Re: American Association for Cancer Research 2019
|
2
|
Zenith Epigenetics
|
Mar 29, 2019 09:05PM
|
|
Zenith MD&A and Financials are up
|
2
|
Zenith Epigenetics
|
Sep 05, 2019 12:52PM
|
|
Re: Resverlax
|
2
|
Resverlogix Corp.
|
Jun 12, 2017 07:26PM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Feb 21, 2020 04:03PM
|
|
Re: New presentation
|
2
|
Resverlogix Corp.
|
Mar 21, 2017 01:45PM
|
|
Re: A vs V
|
2
|
Resverlogix Corp.
|
Mar 29, 2019 09:27PM
|
|
Re: Bromoscan
|
2
|
Resverlogix Corp.
|
Apr 25, 2019 08:32AM
|
|
Re: RVX continuous good news
|
2
|
Resverlogix Corp.
|
Jun 04, 2015 03:21PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Jun 01, 2019 11:49PM
|
|
Re: Great Presetation today
|
2
|
Zenith Epigenetics
|
Oct 21, 2017 11:36AM
|
|
Re: Zenith abstract to be presented at AACR meeting 11/30
|
2
|
Zenith Epigenetics
|
Dec 06, 2016 11:44PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 01:20PM
|
|
Re: Madrid
|
2
|
Resverlogix Corp.
|
Jun 06, 2017 10:06PM
|
|
Re: Resverlogix Announces Participation in Upcoming Conferences
|
2
|
Resverlogix Corp.
|
Nov 02, 2017 05:14PM
|
|
RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 30, 2020 09:12AM
|
|
Former Zacks biotech analyst Napodano charged with fraud
|
2
|
Resverlogix Corp.
|
Sep 27, 2017 01:06PM
|
|
Re: Is $3 by the year's end "far fetched"?
|
2
|
Resverlogix Corp.
|
Sep 29, 2016 06:37AM
|
|
Re: Bear
|
2
|
Zenith Epigenetics
|
Apr 22, 2020 02:33PM
|
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 11:05PM
|
|
Re: Prostate cancer study - combining two existing therapies could extend life by 37%
|
2
|
Zenith Epigenetics
|
Jun 03, 2017 04:46PM
|
